Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.62 USD | -3.56% | -7.87% | -32.78% |
Evolution of the average Target Price on Viridian Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Viridian Therapeutics, Inc.
B. Riley | |
Wedbush | |
Oppenheimer | |
JMP Securities | |
RBC Capital Markets | |
HC Wainwright | |
Needham & Co. | |
Wells Fargo Securities | |
BTIG | |
Stifel Nicolaus | |
SVB Securities LLC | |
Credit Suisse | |
Evercore ISI | |
SVB Leerink | |
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- VRDN Stock
- Consensus Viridian Therapeutics, Inc.